2024³â 11¿ù 01ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Medidata Extends Its Commitment to the Patient Experience with the Launch of Patient Payments

New solution accelerates payments to patients participating in a clinical trial, improving experience and access
´º½ºÀÏÀÚ: 2024-10-10

NEW YORK -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced the launch of Medidata Patient Payments, a new solution that streamlines trial-related stipends and reimbursements for patients participating in clinical research. This offering automates the payment lifecycle and addresses the longstanding challenge of compensating participants for their time, effort, and study-related expenses, while solving for growing concerns around the financial toxicity of clinical trial encounters.

Medidata Patient Payments delivers an intuitive reimbursement experience for patients, allowing them to quickly submit requests for various expenses, including travel, meals, lodging, lost wages, childcare, and mileage. Leveraging the power of the Medidata Platform, stipends are automatically triggered by study activities, such as completing a diary or assessment, offering flexibility and convenience. This integrated approach provides a smooth process, supporting quick implementation and accommodating the preferences of both patients and study sites.

“Our Patient Payments solution is a direct reflection of the commitment and passion we have to deliver an extraordinary patient experience,” said Meghan Harrington, vice president, Clinical Trial Financial Management, Medidata. “Our partnerships with Medidata’s patient and site advisory boards, coupled with the incomparable data housed within our ecosystem, provides us with a unique opportunity to modernize the financial management experience for patients.”

Patient Payments, built on the widely adopted Medidata Platform, offers seamless access via myMedidata for patients and iMedidata accounts for sponsors and sites. Unlike standalone options, it is part of a comprehensive e-clinical suite, enabling robust integration and actionable insights throughout the study lifecycle.



 Àüü´º½º¸ñ·ÏÀ¸·Î

FPT Software Recognized as a Major Player in the IDC MarketScape
ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia ATL5
AMD-Roborobo to operate a joint booth at the Edutech Asia 2024 exhibition
Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials
Asia Pacific IT, Business Services Market Continues to Grow, But Slows From Q2 Levels, Q3 ISG Index Shows
ASDS 2024: New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma¡¯s RelabotulinumtoxinA
LambdaTest Introduces Automated Accessibility Testing with Playwright to Ensure Web Accessibility Compliance

 

Bentley Systems Announces Generative AI Game-Changer for Civil Site De...
Lenovo named Official FIFA Technology Partner
Lenovo's Hybrid AI Advantage with NVIDIA Accelerates Smarter Decision ...
FPT Software's Multi-Million Dollar Investment in Employee Learning an...
Megaport Expands to 14 More Data Centres Across Europe and Strengthens...
ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia ATL5,...
JATCO Drives into the Future with the AI-Native Networking Platform fr...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..